Soongyu Choi
37Patents
10h-index
146Co-inventors
78Inventor score
Filing activity: Sep 28, 2001 → Oct 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9371336B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 31 | Active |
| US9701681B2 | Fused ring heteroaryl compounds and their use as Trk inhibitors | Human Necessities | 30 | Active |
| US9617268B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 28 | Active |
| US7767689B2 | Carboline derivatives useful in the treatment of cancer | Physics | 25 | Active |
| US7601840B2 | Carboline derivatives useful in the inhibition of angiogenesis | Chemistry; Metallurgy | 24 | Active |
| US6784167B2 | 17-beta-hydroxysteroid dehydrogenase-II inhibitors | Chemistry; Metallurgy | 18 | Expired |
| US9586955B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 18 | Active |
| US9879007B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 15 | Active |
| US8143257B2 | Substituted phenols as active agents inhibiting VEGF production | Chemistry; Metallurgy | 11 | Active |
| US8372860B2 | Carboline derivatives useful in the inhibition of angiogenesis | Physics | 11 | Active |
| US6960601B2 | Preparation and use of imidazole derivatives for treatment of obesity | Chemistry; Metallurgy | 10 | Expired |
| US8367694B2 | Carboline derivatives useful in the inhibition of angiogenesis | Chemistry; Metallurgy | 10 | Active |
| US9351964B2 | Methods for treating cancer and non-neoplastic conditions | Emerging Cross-Sectional Technologies | 5 | Active |
| US8946444B2 | Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control | Chemistry; Metallurgy | 4 | Active |
| US9034921B2 | Diphenylmethane derivatives as SGLT2 inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9271960B2 | Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control | Chemistry; Metallurgy | 4 | Active |
| US10752697B2 | Anti-glypican 3 antibody and pharmaceutical composition containing the same | Chemistry; Metallurgy | 3 | Active |
| US10851175B2 | Anti-mesothelin antibody and composition comprising the same | Chemistry; Metallurgy | 2 | Active |
| US9340521B2 | Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives | Chemistry; Metallurgy | 2 | Active |
| US10640496B2 | Method for producing diphenylmethane derivative | Emerging Cross-Sectional Technologies | 1 | Active |
| US10294207B2 | Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same | Chemistry; Metallurgy | 1 | Active |
| USRE47689E1 | Compounds for treating spinal muscular atrophy | General | 0 | Active |
| US8921412B2 | C-aryl ansa SGLT2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11753407B2 | Compounds for treating spinal muscular atrophy | Chemistry; Metallurgy | 0 | Active |
| US7906653B2 | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.